Treatment of human melanoma with a hapten-modified autologous vaccine

Ann N Y Acad Sci. 1993 Aug 12:690:147-52. doi: 10.1111/j.1749-6632.1993.tb44004.x.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Cytotoxicity, Immunologic
  • Dinitrobenzenes / immunology
  • Haptens
  • Humans
  • Immunotherapy, Active
  • Melanoma / therapy*
  • Neoplasm Metastasis
  • Survival Analysis
  • T-Lymphocytes / immunology

Substances

  • Dinitrobenzenes
  • Haptens
  • Cyclophosphamide